EP1725652A4 - Kulturverfahren für cryptosporidium - Google Patents

Kulturverfahren für cryptosporidium

Info

Publication number
EP1725652A4
EP1725652A4 EP05706298A EP05706298A EP1725652A4 EP 1725652 A4 EP1725652 A4 EP 1725652A4 EP 05706298 A EP05706298 A EP 05706298A EP 05706298 A EP05706298 A EP 05706298A EP 1725652 A4 EP1725652 A4 EP 1725652A4
Authority
EP
European Patent Office
Prior art keywords
cryptosporidium
culture methods
culture
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05706298A
Other languages
English (en)
French (fr)
Other versions
EP1725652A1 (de
Inventor
Nawal Hijjawi
Andrew R C Thompson
Una Mary Ryan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Murdoch University
Sydney Water Corp
Original Assignee
Murdoch University
Sydney Water Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004900960A external-priority patent/AU2004900960A0/en
Application filed by Murdoch University, Sydney Water Corp filed Critical Murdoch University
Publication of EP1725652A1 publication Critical patent/EP1725652A1/de
Publication of EP1725652A4 publication Critical patent/EP1725652A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP05706298A 2004-02-26 2005-02-25 Kulturverfahren für cryptosporidium Withdrawn EP1725652A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2004900960A AU2004900960A0 (en) 2004-02-26 Cryptosporidium Propagation Systems
PCT/AU2005/000262 WO2005083055A1 (en) 2004-02-26 2005-02-25 Culture methods for cryptosporidium

Publications (2)

Publication Number Publication Date
EP1725652A1 EP1725652A1 (de) 2006-11-29
EP1725652A4 true EP1725652A4 (de) 2007-08-08

Family

ID=34891636

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05706298A Withdrawn EP1725652A4 (de) 2004-02-26 2005-02-25 Kulturverfahren für cryptosporidium

Country Status (6)

Country Link
US (1) US20080038226A1 (de)
EP (1) EP1725652A4 (de)
JP (1) JP2007527236A (de)
CA (1) CA2557481A1 (de)
WO (1) WO2005083055A1 (de)
ZA (1) ZA200607235B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7582429B2 (en) 2002-10-23 2009-09-01 University Of Utah Research Foundation Amplicon melting analysis with saturation dyes
US9657347B2 (en) 2004-04-20 2017-05-23 University of Utah Research Foundation and BioFire Defense, LLC Nucleic acid melting analysis with saturation dyes
WO2007033398A1 (en) * 2005-09-23 2007-03-29 Murdoch University Cryptosporidium propagation systems
JP5586867B2 (ja) * 2009-03-30 2014-09-10 メタウォーター株式会社 水質自動測定装置及びその方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512288A (en) * 1992-12-04 1996-04-30 University Technologies International, Inc. Giardia vaccine
US20030235903A1 (en) * 2002-06-20 2003-12-25 University Technologies International, Inc. Propagation of cryptosporidium in cell culture

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BRANDT J R A ET AL: "PRELIMINARY OBSERVATIONS ON THE IN-VITRO CULTURE OF METACESTODES OF TAENIA-SAGINATA", VETERINARY SCIENCE COMMUNICATIONS, ELSEVIER SCIENTIFIC PUBLISHING CO., AMSTERDAM, NL, vol. 3, no. 4, 1980, pages 317 - 324, XP008079693, ISSN: 0378-4312 *
GIROUARD DONALD ET AL: "FAILURE TO PROPAGATE CRYPTOSPORIDIUM SPP. IN CELL-FREE CULTURE", JOURNAL OF PARASITOLOGY, AMERICAN SOC. OF PARASITOLOGISTS, WINSTON-SALEM,, US, vol. 92, no. 2, April 2006 (2006-04-01), pages 399 - 400, XP008079680, ISSN: 0022-3395 *
HIJJAWI N S ET AL: "Complete development and long-term maintenance of Cryptosporidium parvum human and cattle genotypes in cell culture", INTERNATIONAL JOURNAL FOR PARASITOLOGY, vol. 31, no. 10, August 2001 (2001-08-01), pages 1048 - 1055, XP007902583, ISSN: 0020-7519 *
See also references of WO2005083055A1 *
WOODS K M ET AL: "In vitro development of Cryptosporidium parvum in serumfree media", LETTERS IN APPLIED MICROBIOLOGY, OXFORD, GB, vol. 44, 2007, pages 520 - 523, XP007902481, ISSN: 1472-765X *

Also Published As

Publication number Publication date
ZA200607235B (en) 2008-06-25
JP2007527236A (ja) 2007-09-27
WO2005083055A1 (en) 2005-09-09
US20080038226A1 (en) 2008-02-14
EP1725652A1 (de) 2006-11-29
CA2557481A1 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
GB2411178A8 (en) Apparatus for culturing cells
EP1950282A4 (de) Kulturvorrichtung
GB0522303D0 (en) Culture method
GB0410118D0 (en) Novel bioreactor
EP1725967A4 (de) Verfahren zur genetischen analyse
IL184262A (en) A method for culturing cells in culture
EP1734110A4 (de) Kulturvorrichtung
GB2418143B (en) Apparatus for behaviour modification
EP1916296A4 (de) Kulturvorrichtung
GB0517382D0 (en) Cell culture
GB0404793D0 (en) Process
EP1753867A4 (de) Fermentationsverfahren
EP1721871A4 (de) Verfahren zur erzeugung von biogas
ZA200802933B (en) Method for culturing microorganisms
GB0420881D0 (en) Bioreactor
EP1725652A4 (de) Kulturverfahren für cryptosporidium
GB0406894D0 (en) Process
IL208214A0 (en) Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
HU0400305D0 (en) Set for spine-fixture
GB0418791D0 (en) Novel process
EP1860943A4 (de) Neuartiges verfahren
TWI315261B (en) Method for transferring-printing
GB0517685D0 (en) Novel method
GB0401540D0 (en) Process
GB0423870D0 (en) Fermentation process

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060925

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20070709

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/68 20060101ALI20070703BHEP

Ipc: C12N 1/10 20060101AFI20050913BHEP

Ipc: C12Q 1/04 20060101ALI20070703BHEP

17Q First examination report despatched

Effective date: 20071017

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20081125